Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Ecotoxicol Environ Saf ; 183: 109468, 2019 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-31398580

RESUMEN

Tephrosia vogelii Hook was excellent insecticidal plant, it was introduced into China and planted over a large area in Guangdong province. The main active components of T. vogelii was rotenone and it widely found in leaves and pods of T. vogelii. This paper study of the safety assessment of T. vogelii flowers to worker bees. In this paper, the content of rotenone in T. vogelii petal, nectar, pollen, pistil, and stamen samples were investigated by HPLC, and tested the toxicity of T. vogelii flowers for Apis cerana cerana during 24 h. The dissipation and dynamic of rotenone in A. c. cerana different biological compartments were investigated under indoor conditions during 24 h. The results showed, The LT50 of T. vogelii flowers to worker bees were collected from the eastern, western, southern, northern and top were 13.95, 24.17, 12.55, 26.48, and 18.84 h, the haemolymph of worker bees have the highest content of rotenone, the least accumulation of rotenone in workers bee's thorax, and the rate of dissipation was slowly during the whole study. In conclusion, the results showed the T. vogelii create security risks to worker bees under some ecosystems.


Asunto(s)
Abejas/efectos de los fármacos , Insecticidas/toxicidad , Rotenona/toxicidad , Tephrosia/química , Animales , China , Ecosistema , Flores/química , Flores/crecimiento & desarrollo , Insecticidas/análisis , Control Biológico de Vectores , Hojas de la Planta/química , Hojas de la Planta/crecimiento & desarrollo , Néctar de las Plantas/química , Polen/química , Rotenona/análisis , Tephrosia/crecimiento & desarrollo
2.
Plant Biol (Stuttg) ; 20(4): 771-779, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29683551

RESUMEN

Eriocaulon buergerianum Körnicke. (Eriocaulaceae) is one of the most common and least expensive herbal medicines for eye disease. This species is facing potential threats from climate change. Insufficient biogeographic knowledge of this plant species can hinder its effective management for long-term population survival. We integrated ecological niche modelling (Biomod2) with 70 records of E. buergerianum and eight environmental variables to estimate changes in distribution over time. A core area Zonation algorithm was introduced to identify conservation priority areas. Our results indicate that the range of E. buergerianum will likely decrease in the future: the overall range change on average is -44.36 ± 21.56% (-3.70% to -77.73%); values of range loss and range gain are 45.79 ± 20.30% (9.29-78.19%) and 1.43 ± 1.53% (0.18-5.59%), respectively. According to conservation priority analysis, the mandatory reserve (top 5%), negotiable reserve (0.95-0.9) and partial reserve (0.9-0.8) areas are 19,799, 19,799 and 39,597 km2 , respectively. The areas identified as conservation priority are located in the southeast, especially in northern Taiwan and the Wuyi Mountains. Based on these results, we suggest a re-evaluation of the threatened status of this species, with a potential upgrade to the vulnerable (VU) category. To overcome the adverse conditions faced by populations of E. buergerianum in China, we propose a multi-faceted conservation strategy involving more complete resource assessment, a monitoring system, medical research focused on revealing medicinal components or substitutes, and a regional development plan that considers both wildlife and socio-economic issues.


Asunto(s)
Eriocaulaceae/fisiología , Plantas Medicinales/fisiología , China , Cambio Climático , Conservación de los Recursos Naturales , Ecosistema , Modelos Biológicos
3.
Eur Rev Med Pharmacol Sci ; 20(19): 4078-4081, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27775790

RESUMEN

OBJECTIVE: Precision medicine is a personalized disease prevention and treatment program combining modern genetic technology, molecular imaging techniques, and biological information with patients' living environment and clinical data, for accurate classification and diagnosis of diseases. CASE REPORT: Our study presents the case of a 7-year-old female patient with clinical manifestations of growth hormone (GH) deficiency. After treatment with recombinant human GH for 2 years, the patient showed a reduced growth rate. Then single nucleotide polymorphisms according to GHD was analyzed, and the 6009 site within cyclin-dependent kinase 4 gene showed a weak response to IGF-1 which was a downstream signal molecules of GH. CONCLUSIONS: Based on these results, both Zn and GH were supplied to the patients, and the growth rate increased significantly. Precision medicine needs more studies on patients to make accurate treatment.


Asunto(s)
Quinasa 4 Dependiente de la Ciclina/genética , Hormona de Crecimiento Humana/uso terapéutico , Polimorfismo de Nucleótido Simple , Zinc/uso terapéutico , Niño , Femenino , Humanos , Factor I del Crecimiento Similar a la Insulina , Medicina de Precisión , Proteínas Recombinantes/uso terapéutico
4.
Plant Dis ; 99(3): 422, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30699710

RESUMEN

The common fig (Ficus carica) is one of the earliest plants domesticated by humans. It has been cultivated in China ever since the early seventh century. Fig fruit is an important traditional Chinese medicine and a fine health food, featuring a unique flavor and rich nutrients. In addition to its great medicinal values, its abundant availability in the Xinjiang province of China has made the fig one of the most popular fruits in the country. One of the major diseases that affect figs is the fig mosaic disease (FMD) (1,4), which was reported in China in 1935 (3). A causal agent of this disease is associated with the Fig mosaic virus (FMV), a negative-strand RNA virus with six RNA segments (2). In 2013, and later during a survey in 2014, fig plants in several orchards in Xinjiang displayed symptoms of a virus-like disease, which was characterized as FMD. These symptoms included chlorotic clearing as well as banding of leaf veins along with various patterns of discoloration, severely distorted leaves, and deformed fruits. Total RNA extracts (TRIzol reagent, Ambion) from 18 symptomatic and four asymptomatic leaf samples were subjected to reverse reaction (RT) assays using M-MLV reverse transcriptase (Promega, Fitchburg, WI) with primer FMV-GP-R (TATTACCTGGATCAACGCAG). PCR analysis of the synthesized cDNA was performed using FMV-specific primers FMV-GP-F (ACTTGCAAAGGCAGATGATA) and FMV-GP-R. Amplicons of 706 bp produced by RT-PCR assays were obtained from most (15 out of 18) of the symptomatic samples; however, none was obtained from the four asymptomatic leaves. The purified amplicons were cloned and sequenced. BLAST analysis of these sequences revealed more than 94% nucleotide identity with glycoprotein precursor (GP) genes of an FMV-Serbia isolate (SB1). One sequence was deposited in NCBI databases, and one sequence was submitted to GenBank (Accession No. KM034915). RNA segments 2 to 6 of FMV were also amplified by RT-PCR and sequenced. These sequences showed 94 to 96% identity with FMV sequences deposited in the NCBI databases. The collected samples were further detected by Northern-blot hybridization with a digoxigenin-labeled RNA probe, which targets the RNA1 genome of the FMV. The result was in line with RT-PCR detection. To our knowledge, this is the first report of FMV in fig trees in China. Considering the economic importance of fig plants and the noxious nature of FMV, this virus poses a great threat to the economy of the fig industry of Xinjiang. Thus, it is important to develop immediate effective quarantine and management of this virus to reduce any further predictable loss. References: (1) T. Elbeaino et al. J. Gen. Virol. 90:1281, 2009. (2) K. Ishikawa et al. J. Gen. Virol. 93:1612, 2012. (3) H. A. Pittman. J. West Aust. Dept. Agric. 12:196, 1935. (4) J. J. Walia et al. Plant Dis. 93:4, 2009.

5.
J Asian Nat Prod Res ; 8(5): 397-400, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16864454

RESUMEN

Nine compounds were isolated from the roots of Valeriana fauriei Briq, of which one is a new germacrane-type sesquiterpenoid named as valerianin E and its structure was elucidated as bicyclo[8, 1, 0] 5beta-hydroxyl-7beta-acetoxyl-5alpha,11, 11'-trimethyl-E-1(10)-ene-4alpha, 15-olide (1). In addition, two were first reported from this genus and the others were isolated for the first time from the title plant.


Asunto(s)
Fitoterapia , Extractos Vegetales/química , Valeriana , Humanos , Espectroscopía de Resonancia Magnética , Raíces de Plantas , Sesquiterpenos/química
6.
Fitoterapia ; 75(3-4): 253-60, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15158981

RESUMEN

The antiinflammatory activity of Terminalia catappa leaves ethanolic extract was studied using 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ear edema in acute and chronic models. A bioassay-oriented fractionation procedure showed that the activity concentrates in the chloroform fraction. Ursolic acid (1) and 2alpha,3beta,23-trihydroxyurs-12-en-28-oic acid (2), isolated from the chloroform fraction, exhibited strong antiinflammatory activities. The results suggest that the triterpenic acids 1 and 2 are responsible for the antiinflammatory activity of T. catappa leaves.


Asunto(s)
Antiinflamatorios/farmacología , Edema/prevención & control , Fitoterapia , Extractos Vegetales/farmacología , Terminalia , Enfermedad Aguda , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Enfermedad Crónica , Relación Dosis-Respuesta a Droga , Edema/inducido químicamente , Masculino , Ratones , Ratones Endogámicos ICR , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Hojas de la Planta , Acetato de Tetradecanoilforbol
7.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 21(3): 183-5, 2001 Mar.
Artículo en Chino | MEDLINE | ID: mdl-12577333

RESUMEN

OBJECTIVE: To find the drugs for lowering the pulmonary vascular resistance in patients of chronic obstructive pulmonary disease (COPD) but would not increase its side-effect. METHODS: Changes of some hemodynamic parameters in 15 patients of COPD in stable stage treated by nitrendipine and ligustrazine were observed by right heart floating catheterization. RESULTS: The mean pulmonary arterial pressure reduced by 1.4% immediately after the combined treatment, and reduced by 17.0%, 20.0% and 18.0% in 15 mins, 30 mins and 60 mins after treatment. In the responding time, the pulmonary vascular resistance reduced by 15.2%, 36.2%, 43.0% and 34.6%, the systemic vascular resistance reduced by 7.9%, 19.2%, 17.9% and 20.8%, and the cardiac output increased by 15.8%, 22.6%, 22.2%, and 33.8% respectively. The changes of systemic arterial pressure and heart rate were of no statistical significance. CONCLUSION: Combination therapy of nitrendipine and ligustrazine could lower the pulmonary arterial pressure and pulmonary vascular resistance effectively and has a selective effect on pulmonary circulation in patients with COPD.


Asunto(s)
Hemodinámica/efectos de los fármacos , Nitrendipino/uso terapéutico , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Pirazinas/uso terapéutico , Vasodilatadores/uso terapéutico , Adulto , Anciano , Bloqueadores de los Canales de Calcio/uso terapéutico , Sinergismo Farmacológico , Quimioterapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología
8.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 21(1): 28-30, 2001 Jan.
Artículo en Chino | MEDLINE | ID: mdl-12577373

RESUMEN

OBJECTIVE: To study the therapeutic mechanism of combination therapy of ligustrazine and nitrendipine in treating patients with chronic obstructive pulmonary disease (COPD). METHODS: Thirty COPD patients divided in to 3 groups (10 in each) were treated with ligustrazine, nitrendipine and ligustrazine plus nitrendipine respectively, and the changes of hemorrheologic parameters, plasma endothelin (ET-1), thromboxane A2(TXA2) and platelet-P-selectin (CD62P) before and after treatment were observed. RESULTS: The combination therapy of ligustrazine and nitrendipine could lower the levels of plasma ET-1, TXA2, CD62P and the hemorrheologic parameters. CONCLUSION: Combination of ligustrazine and nitrendipine showed a therapeutic effect better than that of the two drugs used separately. Its effect in lowering pulmonary circulation resistance is related with the lowering of plasma vaso-contrictive factor and the changing of hemorrheologic properties. The integrated traditional Chinese and western medical therapy is valuable in treating COPD.


Asunto(s)
Nitrendipino/uso terapéutico , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Pirazinas/uso terapéutico , Vasodilatadores/uso terapéutico , Anciano , Quimioterapia Combinada , Endotelina-1/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad , Selectina-P/sangre , Enfermedad Pulmonar Obstructiva Crónica/sangre , Tromboxano B2/sangre
9.
Zhongguo Zhong Yao Za Zhi ; 26(9): 615-6, 2001 Sep.
Artículo en Chino | MEDLINE | ID: mdl-12776430

RESUMEN

OBJECTIVE: To develop a new method for simultaneous determination of oleanolic acid and llrolic acid in Chinese medicinal herbs at the same time. METHOD: HPLC was carried out on a Shim-pack CLC-ODS column using MeOH-H2O-HOAc-TEA (83:17:0.04:0.02). RESULT AND CONCLUSION: The average recovery of oleanolic acid and llrolic acid was 103.3 +/- 2.07% and 102.7% +/- 0.65% respectively.


Asunto(s)
Ácido Oleanólico/análisis , Plantas Medicinales/química , Triterpenos/análisis , Cromatografía Líquida de Alta Presión/métodos , Hedyotis/química , Ligustrum/química , Lycopus/química , Ácido Ursólico
10.
J Nat Prod ; 62(6): 829-32, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10395497

RESUMEN

Five new pregnane glycosides, sinomarinosides A (1), B (2), C (3), D (4), and E (5), have been isolated from Sinomarsdenia incisa (Asclepiadaceae). The structures of these compounds were elucidated by NMR and mass spectroscopic methods and chemical evidence.


Asunto(s)
Plantas Medicinales/química , Pregnanos/química , Secuencia de Carbohidratos , China , Glicósidos/química , Espectroscopía de Resonancia Magnética , Datos de Secuencia Molecular , Espectrometría de Masa Bombardeada por Átomos Veloces
11.
Vaccine ; 17(15-16): 1869-82, 1999 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-10217584

RESUMEN

Yellow fever 17D virus, a safe and effective live, attenuated vaccine, was used as a vector for genes encoding the protective antigenic determinants of a heterologous member of the genus Flavivirus, Japanese encephalitis (JE) virus, the leading cause of acute viral central nervous system infection and death throughout Asia. The viral envelope (prM and E) genes of a full-length cDNA clone of YF 17D virus were replaced with the corresponding genes of JE SA14-14-2, a strain licensed as a live, attenuated vaccine in China. Full-length RNA transcripts of the YF/JE chimaera were used to transfect Vero cells. The progeny virus (named 'ChimeriVax-JE'), was used to define safety after intracerebral (i.c.) inoculation of rhesus monkeys. Monkeys (N = 3) inoculated with a high dose (6.6 log10 pfu) developed a brief viremia, showed no signs of illness, developed high titers of anti-JE neutralizing antibody, and had minimal brain and spinal cord lesion scores according to criteria specified in the WHO monkey neurovirulence test. A control group of 3 monkeys that received a lower dose (4.2 log10 pfu) of commercial YF 17D vaccine had slightly higher lesion scores. To develop a lethal monkey model of JE for vaccine protection tests, we inoculated groups of monkeys i.c. or intranasally (i.n.) with a JE virus strain found to be highly neurovirulent and neuroinvasive for mice. Monkeys inoculated i.c., but not i.n., developed severe encephalitis after an incubation period of 8-13 days. The ChimeriVax-JE virus was passed in a cell line acceptable for human use (diploid fetal rhesus lung) and 4.3 or 5.3 log10 pfu were inoculated into groups of 3 monkeys by the subcutaneous route. All 6 animals developed brief viremias (peak titer < 2.0 log10 pfu/ml) and subsequently had anti-JE but no yellow fever neutralizing antibodies. On day 64, the monkeys were challenged i.c. with 5.5 log10 pfu of virulent JE virus. The immunized animals had no detectable viremia post-challenge, whereas 4 unimmunized controls became viremic. Only 1 of 6 (17%) vaccinated monkeys but 4 of 4 (100%) unvaccinated controls developed encephalitis. Histopathological examination 30 days after challenge confirmed that the protected, immunized animals had no or minimal evidence of encephalitis. These data demonstrated the ability of the ChimeriVax-JE to induce a rapid humoral immune response and to protect against a very severe, direct intracerebral virus challenge. Target areas of neuronal damage and inflammation in monkeys infected IC with wild-type JE, the chimaeric virus and YF 17D were similar, indicating that the histopathological scoring system used for the WHO yellow fever monkey neurovirulence test will be applicable to control testing of chimaeric seed viruses and vaccines.


Asunto(s)
Virus de la Encefalitis Japonesa (Especie)/inmunología , Encefalitis Japonesa/prevención & control , Vacunas Sintéticas/inmunología , Proteínas no Estructurales Virales/inmunología , Proteínas Virales/inmunología , Vacunas Virales/inmunología , Virus de la Fiebre Amarilla/inmunología , Animales , Cápside/genética , Cápside/inmunología , Línea Celular , Sistema Nervioso Central/patología , Sistema Nervioso Central/virología , Relación Dosis-Respuesta Inmunológica , Evaluación Preclínica de Medicamentos , Virus de la Encefalitis Japonesa (Especie)/genética , Virus de la Encefalitis Japonesa (Especie)/crecimiento & desarrollo , Encefalitis Japonesa/patología , Encefalitis Japonesa/virología , Macaca mulatta , Pruebas de Neutralización , Análisis de Secuencia de ADN , Vacunación , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/genética , Vacunas Atenuadas/inmunología , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/genética , Proteínas del Envoltorio Viral/genética , Proteínas del Envoltorio Viral/inmunología , Proteínas no Estructurales Virales/genética , Proteínas Virales/genética , Vacunas Virales/administración & dosificación , Vacunas Virales/genética , Viremia/virología , Virus de la Fiebre Amarilla/genética , Virus de la Fiebre Amarilla/crecimiento & desarrollo
12.
J Infect Dis ; 179 Suppl 1: S240-7, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9988190

RESUMEN

Ebola (subtype Zaire) viral replication was inhibited in vitro by a series of nine nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase, an important target for antiviral drug development. Adult BALB/c mice lethally infected with mouse-adapted Ebola virus die 5-7 days after infection. Treatment initiated on day 0 or 1 resulted in dose-dependent protection, with mortality completely prevented at doses > or =0.7 mg/kg every 8 h. There was significant protection (90%) when treatment was begun on day 2, at which time, the liver had an average titer of 3 x 10(5) pfu/g virus and the spleen had 2 x 10(6) pfu/g. Treatment with 2.2 mg/kg initiated on day 3, when the liver had an average titer of 2 x 10(7) pfu/g virus and the spleen had 2 x 10(8) pfu/g, resulted in 40% survival. As reported here, Carbocyclic 3-deazaadenosine is the first compound demonstrated to cure animals from this otherwise lethal Ebola virus infection.


Asunto(s)
Antivirales/uso terapéutico , Ebolavirus/efectos de los fármacos , Inhibidores Enzimáticos/uso terapéutico , Hidrolasas/antagonistas & inhibidores , Adenosilhomocisteinasa , Animales , Antivirales/química , Chlorocebus aethiops , Modelos Animales de Enfermedad , Evaluación de Medicamentos , Evaluación Preclínica de Medicamentos , Ebolavirus/patogenicidad , Inhibidores Enzimáticos/química , Fiebre Hemorrágica Ebola/tratamiento farmacológico , Fiebre Hemorrágica Ebola/virología , Técnicas In Vitro , Hígado/virología , Ratones , Ratones Endogámicos BALB C , Bazo/virología , Factores de Tiempo , Tubercidina/análogos & derivados , Tubercidina/uso terapéutico , Células Vero
13.
Am J Reprod Immunol ; 39(3): 217-22, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9526611

RESUMEN

PROBLEM: Cytokine-induced neutrophil chemoattractant (CINC) was reported to influence anterior pituitary hormone release. We recently found that Unkei-to, one of the Japanese Kampo medicines, stimulated CINC secretion by rat anterior pituitary cells and the pituitary folliculo-stellate (FS)-like cell line (TtT/GF). Therefore, the effect of Unkei-to on growth hormone (GH) secretion by rat anterior pituitary cells was investigated. METHOD OF STUDY: Dispersed normal anterior pituitary cells, the folliculo-stellate-like cell line TtT/GF, and the GH3 cell were used to test the effect of Unkei-to on GH secretion. In reconstitutive coculture experiments, TtT/GF cells were mixed with GH3 cells at a ratio (TtT/GF cells: GH3 cells) of 1:99. From this mixture, cells were seeded onto plates at a density of 10(4) cells/well and were cultured for 5 days. The cells were then used in the experiments. RESULTS: Unkei-to at 20 micrograms/ml significantly inhibited GH secretion by normal anterior pituitary cells within 12 hr of incubation. In contrast Unkei-to stimulated GH secretion by GH3 cells in a time- and dose-dependent manner, suggesting that an accessory cell type was involved. To assess the contribution of CINC as a paracrine factor, an experiment using a reconstitutive coculture system was performed, and Unkei-to was found to inhibit GH secretion when GH3 cells were cocultured with TtT/GF cells. The addition of anti-CINC antibody to the reconstitutive coculture system antagonized Unkei-to-inhibited GH secretion. CONCLUSION: CINC, which was secreted from FS cells by Unkei-to, may be responsible for mediating the inhibitory effect of Unkei-to on GH secretion by rat anterior pituitary cells.


Asunto(s)
Quimiocinas CXC , Medicamentos Herbarios Chinos/farmacología , Hormona del Crecimiento/metabolismo , Péptidos y Proteínas de Señalización Intercelular , Adenohipófisis/efectos de los fármacos , Adenohipófisis/metabolismo , Animales , Células Cultivadas , Factores Quimiotácticos/farmacología , Técnicas de Cocultivo , Femenino , Inhibidores de Crecimiento/farmacología , Sustancias de Crecimiento/farmacología , Adenohipófisis/citología , Ratas , Ratas Wistar
14.
Am J Reprod Immunol ; 39(4): 249-55, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9553649

RESUMEN

PROBLEM: We previously reported that a cytokine-induced neutrophil chemoattractant (CINC) was produced in the pituitary gland and that it influenced anterior pituitary hormone release. In this study we investigated the effect of Unkei-to, a Japanese herbal medicine, on CINC production in the rat anterior pituitary gland and the pituitary folliculo-stellate-like cell line (TtT/GF). METHOD OF STUDY: Dispersed normal anterior pituitary cells and the folliculo-stellate-like cell line TtT/GF were used to test the effect of Unkei-to on CINC secretion and CINC mRNA accumulation. Concentrations of CINC in the conditioned media were measured by an enzyme-linked immunosorbent assay, and levels of CINC mRNA were analyzed by Northern blot analysis. RESULTS: Unkei-to (20 micrograms/ml) significantly increased the secretion of CINC by normal anterior pituitary cells within 12 hr of incubation. Unkei-to also stimulated CINC secretion from TtT/GF cells in a time- and dose-dependent manner. Unkei-to (20 micrograms/ml) increased CINC mRNA accumulation in TtT/GF cells within 3 hr of incubation and also caused a 13-fold increase in the secretion of CINC from TtT/GF cells compared with the vehicle group within 24 hr of incubation. Finally, we found that some of the Unkei-to's ingredients, Evodiae fructus and Pinelliae tuber, markedly stimulated CINC secretion from TtT/GF cells. CONCLUSIONS: Our results will help to elucidate the mechanism behind the clinical effect of Unkei-to on the anterior pituitary gland. They also suggested the presence of special substances, which stimulate CINC secretion, within Unkei-to's ingredients such as E. fructus and P. tuber.


Asunto(s)
Quimiocinas CXC , Factores Quimiotácticos/metabolismo , Citocinas/farmacología , Medicamentos Herbarios Chinos/farmacología , Sustancias de Crecimiento/metabolismo , Péptidos y Proteínas de Señalización Intercelular , Medicina Tradicional de Asia Oriental , Adenohipófisis/efectos de los fármacos , Plantas Medicinales , Animales , Línea Celular , Factores Quimiotácticos/genética , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Femenino , Sustancias de Crecimiento/genética , Adenohipófisis/citología , ARN Mensajero/análisis , Ratas , Ratas Wistar
15.
Sheng Li Ke Xue Jin Zhan ; 29(1): 29-34, 1998 Jan.
Artículo en Chino | MEDLINE | ID: mdl-12501700

RESUMEN

Selenium is an essential trace element for animals and humans. Selenium exerts its biological function largely through selenoproteins. Up to now nine selenoproteins' cDNAs have been cloned and sequenced, which are cellular glutathione peroxidase (cGPX), extracellular glutathine peroxidase(eGPX), phospholipid hydroperoxidase glutathione peroxidase(PHGPX), gastrointestinal glutathione peroxidase (GPX-GI), type I iodothyronine 5'-deiodinase (ID I), type 2 iodothyronine 5'-deiodinase(ID II), type III iodothyronine 5-deiodinase(ID III), selenoprotein P (Se-P) and selenoprotein W. In all these selenoproteins Se is incorporated into the protein molecule via the selenocysteinyl-tRNA which recognizes the specific UGA codons in mRNA to insert selenocysteine into the primary structure of selenoproteins.


Asunto(s)
Biosíntesis de Proteínas , Selenio , Animales , Glutatión Peroxidasa/biosíntesis , Glutatión Peroxidasa/genética , Humanos , Fosfolípido Hidroperóxido Glutatión Peroxidasa , Proteínas/genética , ARN Mensajero/genética , Selenoproteína P , Selenoproteína W , Selenoproteínas
16.
Zhongguo Yao Li Xue Bao ; 18(4): 344-7, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10072919

RESUMEN

AIM: To determine whether the extract of leaves of Ginkgo biloba L (EGb) and several active constituents of EGb have protective effects against glutamate (Glu)-induced neuronal damage. METHODS: Microscopy and image analysis of nucleus areas in the arcuate nuclei (AN) of mice were made. The neuronal viability in primary cultures from mouse cerebral cortex was assessed using MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide] staining and the intracellular free calcium concentration ([Ca2+]i) of single neuron was measured using Fura-2. RESULTS: EGb (2.5 mg.L-1) and its constituent ginkgolide B (Gin B, 2 mg.L-1) protected the neuronal viability against Glu-induced injury, and prevented the Glu-induced elevation in [Ca2+]i. EGb (3-10 mg.kg-1) attenuated the decrease of nucleus areas in arcuate nuclei induced by Glu (1 g.kg-1, s.c.). CONCLUSION: EGb and Gin B prevent neurons from Glu neurotoxicity through reduction of the rise in [Ca2+]i.


Asunto(s)
Núcleo Arqueado del Hipotálamo/efectos de los fármacos , Calcio/metabolismo , Diterpenos , Ginkgo biloba , Lactonas/farmacología , Plantas Medicinales , Animales , Núcleo Arqueado del Hipotálamo/metabolismo , Células Cultivadas , Corteza Cerebral/citología , Feto , Ginkgólidos , Ácido Glutámico , Ratones , Extractos Vegetales/farmacología , Hojas de la Planta
17.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 17(2): 76-8, 1997 Feb.
Artículo en Chino | MEDLINE | ID: mdl-9812660

RESUMEN

OBJECTIVE: To observe the efficacy of the colonic dialysis therapy of Chinese medicine in abstinance of heroin addicts. METHODS: One hundred and twenty five cases of heroin addicts were randomly divided into two groups: group A was treated with combined dihydroetorphine (DHE) and methadon therapy; group B, besides DHE and methadon, the addicts were given colon dialysis with Chinese herbal medicine from third day of the treatment through to the eighth day. RESULTS: The effect of group B was superior to that of group A in that the patients heroin abstinance symptoms disappeared more rapidly, the course of the disease was shorter and the effective rate raised to 100%. CONCLUSION: The cutaneous pigmentation could be removed through dialysis quickly which suggested that the method was able to remove toxic substances in the body and it would benefit the abstinance of heroin addicts.


Asunto(s)
Medicamentos Herbarios Chinos/administración & dosificación , Dependencia de Heroína/tratamiento farmacológico , Adolescente , Adulto , Analgésicos Opioides/uso terapéutico , Colon , Diálisis/métodos , Etorfina/análogos & derivados , Etorfina/uso terapéutico , Femenino , Estudios de Seguimiento , Humanos , Masculino , Metadona/uso terapéutico
18.
J Basic Clin Physiol Pharmacol ; 8(4): 301-14, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9651802

RESUMEN

Calcium channel blockers are used as neuroprotective agents, as glutamate antagonists. However, it has been found that calcium channel blockers may compromise neuronal survival after long-term exposure. To explore the mechanisms of the toxicity of calcium channel blockers on neurons, we studied the morphological characteristics and biochemical changes of cultured cortical neurons treated with verapamil, a calcium channel blocker. We now report that cerebral cortical cultures exposed to verapamil for 48 h undergo neuronal degeneration in both concentration-dependent and time-dependent fashion, possibly partially through the activation of apoptosis. On the other hand, it was found that Ginkgo biloba extract (EGb761) attenuated verapamil-induced neuronal injury, suggesting the possibility of using verapamil combined with EGb761 clinically. Furthermore, both B-50 immunoactivity (BIA) and the concentration of intracellular calcium in single neurons ([Ca2+]i) decreased after a 48-h exposure to verapamil, suggesting that the mechanisms of verapamil-induced degeneration may be associated with the disruption of intracellular calcium homeostasis and the inhibition of normal axonal elongation.


Asunto(s)
Bloqueadores de los Canales de Calcio/toxicidad , Corteza Cerebral/ultraestructura , Diterpenos , Flavonoides/farmacología , Degeneración Nerviosa/inducido químicamente , Neuronas/ultraestructura , Extractos Vegetales , Verapamilo/toxicidad , Animales , Apoptosis/efectos de los fármacos , Axones/química , Axones/efectos de los fármacos , Axones/fisiología , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Corteza Cerebral/efectos de los fármacos , Proteína GAP-43/análisis , Ginkgo biloba , Ginkgólidos , Lactonas/farmacología , Ratones , Degeneración Nerviosa/patología , Neuronas/efectos de los fármacos , Factores de Tiempo , Verapamilo/antagonistas & inhibidores
19.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 15(3): 131-3, 1995 Mar.
Artículo en Chino | MEDLINE | ID: mdl-7647523

RESUMEN

In order to study the effect of dihydroxyacetophenone (DHAP) on pulmonary hemodynamics and its relationship to plasma ANP as well as cAMP/cGMP level in chronic obstructive pulmonary disease (COPD), 11 COPD patients were examined with the right heart catheterisation, and the plasma ANP and cAMP/cGMP were measured with radioimmunoassay at the same time. The results showed that intravenous given DHAP 640 mg could decrease mean pulmonary arterial pressure, pulmonary vascular resistance and systemic vascular resistance (P < 0.05), but increase the cardiac output from 4.10 +/- 1.08 L/min to 5.13 +/- 1.19 L/min (P > 0.05) and not affect systemic arterial pressure (P > 0.05) as well as blood gas analysis; it also reduce the plasma ANP and cGMP level from 0.73 +/- 0.42 pg/ml to 0.41 +/- 0.33 pg/ml (P < 0.01) and from 9.82 +/- 5.75 pm/ml to 8.01 +/- 4.80 pm/ml (P < 0.05) respectively, but did not affect the plasma cAMP level (P > 0.05). It is suggested that DHAP may relax pulmonary vessels by regulating the ratio of cAMP to cGMP, and the lowering of plasma ANP level might be a secondary reaction. So we consider that DHAP is a fast-acting, safe and potential drug in treating pulmonary arterial hypertension by COPD.


Asunto(s)
Acetofenonas/farmacología , Enfermedades Pulmonares Obstructivas/fisiopatología , Circulación Pulmonar/efectos de los fármacos , Adulto , Anciano , Factor Natriurético Atrial/sangre , Presión Sanguínea/efectos de los fármacos , AMP Cíclico/sangre , GMP Cíclico/sangre , Femenino , Hemodinámica/efectos de los fármacos , Humanos , Enfermedades Pulmonares Obstructivas/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Resistencia Vascular/efectos de los fármacos
20.
Zhongguo Yao Li Xue Bao ; 15(2): 161-4, 1994 Mar.
Artículo en Chino | MEDLINE | ID: mdl-8010113

RESUMEN

The neurotoxic effects of sodium glutamate (MSG, 2.5 g.kg-1 sc) and the enhancing effects of neurotropic Herpesvirus hominis (HVH, 0.2 ml/mouse ip) on MSG toxicity were studied through histomorphological observations, together with detection of the concentration of both mitochondrial protein bound Ca2+ and intracellular free Ca2+ ([Ca2+]i) by the Tb3+ fluorescent probe and Ca2+ indicator Fura-2/AM, respectively. It was found that in 10-d-old mice the neurons in arcuate hypothalamic nucleus degenerated severely after treatment with HVH+MSG, showing swollen edematous cytoplasm, dark pyknotic nuclei as well as a decrease in the amount of the neurons. The hypothalamic and spinal cord mitochondrial Tb3+ relative fluorescent intensity increased from 20 +/- 3 and 20 +/- 1 to 28 +/- 5 and 34 +/- 6, ie, the mitochondrial protein bound Ca2+ reduced significantly. MSG elevated the [Ca2+]i levels from 0.11 +/- 0.03 to 0.69 +/- 0.19 mumol.L-1 by not only stimulating the Ca2+ influx but also releasing the Ca2+ from intracellular stores. These findings suggested that MSG neurotoxicity was probably related to the overloading of neuroplasmic Ca2+, the destruction of neuronal abilities to deplete or sequester the intracellular Ca2+, as well as the irreversible neuronal injury and death.


Asunto(s)
Núcleo Arqueado del Hipotálamo/efectos de los fármacos , Simplexvirus/patogenicidad , Glutamato de Sodio/toxicidad , Animales , Calcio/metabolismo , Femenino , Hipotálamo/efectos de los fármacos , Masculino , Ratones , Mitocondrias/metabolismo , Neuronas , Médula Espinal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA